Gabriela Corrêa-Castro

Gabriela Corrêa-Castro

Auto-generated profile, based on publicly available information

Gabriela Corrêa-Castro


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2025 in SSRN Electronic Journal
Verified
Preprint
Open access
MGMarina Vieira Agostinho Galvani
Marina Vieira Agostinho Galvani
KOKarina da Silva Oliveira
Karina da Silva Oliveira
FXFelipe Henrique da Cunha Xavier
Felipe Henrique da Cunha Xavier
IAItauá Leston Araujo
Itauá Leston Araujo
PLPaulo Correa Leite
Paulo Correa Leite
RGRômulo Gonçalves Agostinho Galvani
Rômulo Gonçalves Agostinho Galvani
Background: Cytokine dysregulation increases severe disease risk. Using inflammatory biomarkers and T/B cell dynamics, we developed predictive machine learning model to identify individuals at high-risk pre-infection.Methods: We conducted a pooled cross-sectional study from two macro projects in Rio de Janeiro, Brazil. Both used qRT-PCR to identify infected patients and classified cases as symptomatic or asymptomatic. Levels of 48 cytokines were quantified, and a machine learning model was developed to predict individuals who would develop symptomatic disease. We also measured T and B cell neogenesis by quantifying TRECs (T-cell Receptor Excision Circles) and KRECs (kappa-Deleting Recombination Excision Circles).Findings: Correlation network modeling revealed distinct immune coordination. Asymptomatic individuals displayed linked cytokine networks associated with antimicrobial humoral immune response mediated by antimicrobial peptide, positive regulation of leukocyte differentiation and lymphocyte mediated immunity, while symptomatic cases exhibited sparse networks, lower humoral immune response and natural killer chemotaxis. The machine learning model identified key cytokines as predictors of disease symptoms, achieving a robust AUC of 0·788, as high as 0·857 in Accuracy, 0·815 in F1-Score, 0·705 in Kappa, 0·792 in Positive Predictive Value and 1 in Negative Predictive Value for prediction of symptomatic risk. Thymic output biomarkers were comparable across groups. However, when B-cell dynamics were assessed, symptomatic individuals showed elevated recent B-cell production (sjKREC levels), while asymptomatic cases exhibited previous clonal B-cell expansions.Interpretation: These findings indicate that the pre-existing immune profile can predict asymptomatic or symptomatic disease. This research highlights the potential of cytokine profiling and machine learning for early risk stratification, aiding vaccine prioritization in future pandemics or seasonal outbreaks.

6 August 2026 in Microbial Pathogenesis
Verified
Journal Article
Open access
GCGabriela Corrêa-Castro
Gabriela Corrêa-Castro
MSMaria Luciana Silva-Freitas
Maria Luciana Silva-Freitas
LPLudmila de Paula
Ludmila de Paula
MDMaria Rita Teixeira Dutra
Maria Rita Teixeira Dutra
LPLeonardo Soares Pereira
Leonardo Soares Pereira
JSJoanna Reis Santos-Oliveira
Joanna Reis Santos-Oliveira

11 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
GCGabriela Corrêa-Castro
Gabriela Corrêa-Castro
MSMaria Luciana Silva-Freitas
Maria Luciana Silva-Freitas
LPLudmila de Paula
Ludmila de Paula
MDMaria Rita Teixeira Dutra
Maria Rita Teixeira Dutra
LPLeonardo Soares Pereira
Leonardo Soares Pereira
JSJoanna Santos-Oliveira
Joanna Santos-Oliveira
Visceral leishmaniasis (VL) is a severe disease caused by Leishmania infantum in Brazil. Relapses have increased among immunocompetent patients; however, the underlying factors remain unclear. Persistently low CD4+ T cell counts had been associated with VL relapses, suggesting impaired immune reconstitution. Here, we investigated whether immune activation and thymic function influence immune recovery in VL and shape the TCRVβ repertoire, predisposing patients to relapse. Patients with VL, followed for 12 months, were stratified according to relapse (R-VL,n=5) or non-relapse (NR-VL,n=10). Immune activation, senescence, and the TCRVβ repertoire were evaluated using flow cytometry, and thymic function was assessed through sjTREC quantification in CD4+ and CD8+ T cells. Plasma IL-7 levels were also measured. R-VL patients exhibited sustained immune activation, in contrast to the decline observed in NR-VL. Both groups showed high levels of immunosenescence throughout the follow-up period. All patients had low sjTREC levels during active VL; however, post-treatment levels were even lower in R-VL patients and were associated with reduced IL-7 levels. TCRVβ repertoire analysis showed differential mobilization between patients in the NR-VL and R-VL groups. Correlation analysis suggested that deficient thymic output may impair T cell replenishment, which is crucial for parasite control. Linear mixed-effects modeling showed that CD4+ T cell counts were influenced by synergistic effect between sjTREC and IL-7, as well were correlated with activation. In conclusion, our study showed that VL relapse is associated with multifactorial dysfunction that compromises immune reconstitution, highlighting the roles of sustained immune activation, thymic impairment, and peripheral disturbances in clinical outcomes.